These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 10776929)

  • 1. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier.
    Lee YM; Park YJ; Lee SJ; Ku Y; Han SB; Klokkevold PR; Chung CP
    J Periodontol; 2000 Mar; 71(3):418-24. PubMed ID: 10776929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration.
    Park YJ; Lee YM; Park SN; Sheen SY; Chung CP; Lee SJ
    Biomaterials; 2000 Jan; 21(2):153-9. PubMed ID: 10632397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration.
    Park YJ; Lee YM; Lee JY; Seol YJ; Chung CP; Lee SJ
    J Control Release; 2000 Jul; 67(2-3):385-94. PubMed ID: 10825569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineered bone formation using chitosan/tricalcium phosphate sponges.
    Lee YM; Park YJ; Lee SJ; Ku Y; Han SB; Choi SM; Klokkevold PR; Chung CP
    J Periodontol; 2000 Mar; 71(3):410-7. PubMed ID: 10776928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.
    Ahn SH; Kim CS; Suk HJ; Lee YJ; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2003 Jun; 74(6):787-97. PubMed ID: 12886988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with Augment(TM) Bone Graft or GEM 21S beta-tricalcium phosphate (beta-TCP).
    Young CS; Ladd PA; Browning CF; Thompson A; Bonomo J; Shockley K; Hart CE
    J Control Release; 2009 Dec; 140(3):250-5. PubMed ID: 19577598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rhPDGF-BB on bone turnover during periodontal repair.
    Sarment DP; Cooke JW; Miller SE; Jin Q; McGuire MK; Kao RT; McClain PK; McAllister BS; Lynch SE; Giannobile WV
    J Clin Periodontol; 2006 Feb; 33(2):135-40. PubMed ID: 16441739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor enhancement of two alloplastic bone matrices.
    Bateman J; Intini G; Margarone J; Goodloe S; Bush P; Lynch SE; Dziak R
    J Periodontol; 2005 Nov; 76(11):1833-41. PubMed ID: 16274301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molded porous poly (L-lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release.
    Lee SJ; Park YJ; Park SN; Lee YM; Seol YJ; Ku Y; Chung CP
    J Biomed Mater Res; 2001 Jun; 55(3):295-303. PubMed ID: 11255182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
    Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.
    Jayakumar A; Rajababu P; Rohini S; Butchibabu K; Naveen A; Reddy PK; Vidyasagar S; Satyanarayana D; Pavan Kumar S
    J Clin Periodontol; 2011 Feb; 38(2):163-72. PubMed ID: 21133980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor enhancement of a mineral-collagen bone substitute.
    Stephan EB; Renjen R; Lynch SE; Dziak R
    J Periodontol; 2000 Dec; 71(12):1887-92. PubMed ID: 11156046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoconductive effects of vinyl styrene microbeads in rat calvarial defects.
    Marzouk KM; Gamal AY; Al-Awady AA; Sharawy MM
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1508-16. PubMed ID: 17656276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor BB treated osteoprogenitors inhibit bone regeneration.
    Marzouk KM; Gamal AY; Al-Awady AA; Sharawy MM
    J Oral Implantol; 2008; 34(5):242-7. PubMed ID: 19170289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth/differentiation factor-5 significantly enhances periodontal wound healing/regeneration compared with platelet-derived growth factor-BB in dogs.
    Kwon HR; Wikesjö UM; Park JC; Kim YT; Bastone P; Pippig SD; Kim CK
    J Clin Periodontol; 2010 Aug; 37(8):739-46. PubMed ID: 20618546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone healing with oxytocin-loaded microporous β-TCP bone substitute in ectopic bone formation model and critical-sized osseous defect of rat.
    Park JW; Kim JM; Lee HJ; Jeong SH; Suh JY; Hanawa T
    J Clin Periodontol; 2014 Feb; 41(2):181-90. PubMed ID: 24256613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant PDGF-BB on bone formation in the presence of β-tricalcium phosphate and bovine bone mineral matrix: a pilot study in rat calvarial defects.
    Luvizuto ER; Tangl S; Dobsak T; Reich K; Gruber R; Sonoda CK; Okamoto R
    BMC Oral Health; 2016 May; 16(1):52. PubMed ID: 27145819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone formation using β-tricalcium phosphate/carboxymethyl-chitin composite scaffold in rat calvarial defects.
    Taniyama K; Shirakata Y; Yoshimoto T; Takeuchi N; Yoshihara Y; Noguchi K
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):e450-6. PubMed ID: 22901650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor releasing porous poly (epsilon-caprolactone)-chitosan matrices for enhanced bone regenerative therapy.
    Im SY; Cho SH; Hwang JH; Lee SJ
    Arch Pharm Res; 2003 Jan; 26(1):76-82. PubMed ID: 12568363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.